Agilent, SAT Ink Pact to Provide Automated SISCAPA Workflows for Protein Quantitation | GenomeWeb

NEW YORK (GenomeWeb) – Agilent Technologies and SISCAPA Assay Technologies said today that they have signed a non-exclusive agreement to provide complete workflows for targeted protein quantitation.

The workflows combine SAT's SISCAPA reagents for immunoenrichment mass spec-based protein quantitation with Agilent's Bravo automated liquid handling platform for sample prep and LC/MS systems, including Agilent's RapidFire high-throughput LC/MS system, for quantitative analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.